BioVie Inc. logo

BioVie Inc.

NASDAQ:BIVI

Overview | Financials
Company Name BioVie Inc.
Symbol BIVI
Currency USD
Price 2.49
Market Cap 15,230,210
Dividend Yield 0%
52-week-range 2.07 - 58.2
Industry Biotechnology
Sector Healthcare
CEO Mr. Cuong Viet Do M.B.A., MBA
Website https://bioviepharma.com

An error occurred while fetching data.

About BioVie Inc.

BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III

Related Stocks

Lantern Pharma Inc. logo

Lantern Pharma Inc.

LTRN

3.42 USD

CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc.

CASI

6.5 USD

Achieve Life Sciences, Inc. logo

Achieve Life Sciences, Inc.

ACHV

4.165 USD

Dyadic International, Inc. logo

Dyadic International, Inc.

DYAI

1.26 USD

SELLAS Life Sciences Group, Inc. logo

SELLAS Life Sciences Group, Inc.

SLS

1.19 USD

Great Elm Group, Inc. logo

Great Elm Group, Inc.

GEG

1.87 USD

Silver Spike Investment Corp. logo

Silver Spike Investment Corp.

SSIC

11.46 USD

Financials

Numbers are in millions USD

Numbers are in millions USD